Cerenome (CNSY) Net Income towards Common Stockholders (QoQ) (2011 - 2026)
Powered by 
Analysis
Cerenome (CNSY) Net Income towards Common Stockholders (QoQ) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 10 | Cerenome | 20.42 Mn | 11.83 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -29.66% |
| Mar 31, 2026 | -21.58% |
| Dec 31, 2025 | -29.17% |
| Sep 30, 2025 | -471.37% |
| Jun 30, 2025 | 129.17% |
| Mar 31, 2025 | -4.61% |
| Dec 31, 2024 | -3.25% |
| Sep 30, 2024 | -3.36% |
| Jun 30, 2024 | -12.14% |
| Mar 31, 2024 | 14.41% |
| Dec 31, 2023 | -18.36% |
| Sep 30, 2023 | -117.21% |
| Jun 30, 2023 | 69.16% |
| Mar 31, 2023 | 14.35% |
| Dec 31, 2022 | -6.94% |
| Sep 30, 2022 | 1.04% |
| Jun 30, 2022 | -28.70% |
| Mar 31, 2022 | 0.91% |
| Dec 31, 2021 | -11.57% |
| Sep 30, 2021 | -33.07% |